AtriCure, Inc.ATRCEarnings & Financial Report
Nasdaq
NextMar 31, 2026
ATRC Q3 2025 Key Financial Metrics
Revenue
$134.3M
Gross Profit
$101.3M
Operating Profit
$208.0K
Net Profit
$-267.0K
Gross Margin
75.5%
Operating Margin
0.2%
Net Margin
-0.2%
YoY Growth
15.8%
EPS
$-0.01
Financial Flow
AtriCure, Inc. Q3 2025 Financial Summary
AtriCure, Inc. reported revenue of $134.3M for Q3 2025, with a net profit of $-267.0K (-0.2% margin). Cost of goods sold was $32.9M, operating expenses totaled $101.1M.
Key Financial Metrics
| Total Revenue | $134.3M |
|---|---|
| Net Profit | $-267.0K |
| Gross Margin | 75.5% |
| Operating Margin | 0.2% |
| Report Period | Q3 2025 |
AtriCure, Inc. Annual Revenue by Year
AtriCure, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $465.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $465.3M |
| 2023 | $399.2M |
| 2022 | $330.4M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $106.5M | $108.9M | $116.3M | $115.9M | $124.3M | $123.6M | $136.1M | $134.3M |
| YoY Growth | 21.0% | 16.4% | 15.2% | 17.9% | 16.6% | 13.6% | 17.1% | 15.8% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $613.9M | $591.6M | $597.3M | $615.1M | $609.3M | $591.6M | $608.8M | $635.4M |
| Liabilities | $147.8M | $135.3M | $135.2M | $150.0M | $148.4M | $137.0M | $144.4M | $158.9M |
| Equity | $466.2M | $456.3M | $462.1M | $465.0M | $461.0M | $454.6M | $464.5M | $476.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.0M | $-21.0M | $7.4M | $20.0M | $5.8M | $-11.0M | $21.6M | $26.7M |